Study of Safety, Tolerability, Preliminary Efficacy of Intra-articular LNA043 Injections in Patients With Articular Cartilage Lesions and Knee Osteoarthritis.
NCT03275064
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
142
Enrollment
INDUSTRY
Sponsor class
Conditions
Osteoarthritis
Interventions
BIOLOGICAL:
LNA043
OTHER:
Placebo
Sponsor
Novartis Pharmaceuticals